openPR Logo
Press release

Non-Invasive Prenatal Testing Market to Witness Robust Growth on Account of Growing Chromosomal Abnormalities among Infants By 2027 | Top Keys: PerkinElmer Inc., Natera Inc., F. Hoffmann La Roche Ltd

11-12-2019 12:35 PM CET | Health & Medicine

Press release from: Research Nester Pvt Ltd

Non-Invasive Prenatal Testing Market to Witness Robust Growth

Research Nester released a report titled “Non-Invasive Prenatal Testing Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global non-invasive prenatal testing market in terms of market segmentation by product, by application, by end user and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

Non-invasive prenatal testing is a screening test that helps in the detection of any abnormalities or birth defects that might be present in the fetus. It works by screening or analyzing the free-floating DNA fragments present in the blood of pregnant women. The market for non-invasive prenatal testing is predicted to grow by a CAGR of 12.80% during the forecast period, i.e., 2020-2027.

Get Exclusive Sample Report Copy Of This Report @ https://www.researchnester.com/sample-request-2098

The market value is estimated to reach USD 6,406.77 million by 2027 from a value of USD 2,168.79 million in 2018. The market is segmented by product, by application, by end user and by region, out of which, the product segment is further segmented into Elisa kits, next generation sequencing systems and microarray analysis. On the basis of product, the next generation sequencing systems segment is anticipated to observe the highest growth as a result of it being an advanced method for genome sequencing.

The global non-invasive prenatal testing market is segmented by regions into North America, Latin America, Europe, Asia-Pacific and Middle East and Africa, out of which, the markets in North America and Europe are anticipated to hold significantly large shares. This can be attributed to the changing environmental conditions which result in development of various genetic health disorders such as cancers. Moreover, the increasing exposure of x-rays and gamma rays is another factor responsible for market growth in this region.

Early Detection Of Genetic Disorders Made Possible By Non-Invasive Prenatal Testing Technique

According to March of Dimes, about 1 in 150 babies are born with abnormal chromosomal conditions. The disorders arising due to genetic mutations such as Down syndrome develop into serious heart conditions in the later stage of life which require surgical treatments and regular monitoring. In order to prevent this, NIPT screening can be done so as to diagnose the condition at early stages and treat them. This is predicted to be a major growth driver for the market during the forecast period. However, the lack of knowledge about the offered screening and diagnostic tests for Down syndrome, especially NIPT, is anticipated to hinder the market growth.

This report also provides the existing competitive scenario of some of the key players of the global non-invasive prenatal testing market which includes company profiling:
PerkinElmer Inc.,
Natera Inc.,
F. Hoffmann La Roche Ltd.,
Yourgene Health plc,
BGI,
Illumina Inc.,
Agilent Technologies Inc.,
Laboratory Corporation of America Holdings and Quest Diagnostics.

The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global non-invasive prenatal testing market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Get more info @ https://www.researchnester.com/reports/non-invasive-prenatal-testing-market/2098

Contact for more Info:

AJ Daniel

Email: sales@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

About Research Nester:

Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-Invasive Prenatal Testing Market to Witness Robust Growth on Account of Growing Chromosomal Abnormalities among Infants By 2027 | Top Keys: PerkinElmer Inc., Natera Inc., F. Hoffmann La Roche Ltd here

News-ID: 1865653 • Views:

More Releases from Research Nester Pvt Ltd

Lutein and Zeaxanthin Market - Key Players, Capability Assessment & M&A Indicators
Lutein and Zeaxanthin Market - Key Players, Capability Assessment & M&A Indicato …
The lutein and zeaxanthin market has expanded steadily as demand for eye-health supplements, functional foods, and preventive nutrition increases across global consumer segments. Lutein and zeaxanthin, two essential carotenoids concentrated in the retina, are widely recognized for their protective roles against oxidative stress, age-related macular degeneration (AMD), blue-light exposure, and general visual fatigue. Their adoption has accelerated with the rise of digital lifestyles, an aging population, and growing clinical evidence
Top Companies in Atrial Fibrillation Market - Benchmarking Performance & Future Value Creation
Top Companies in Atrial Fibrillation Market - Benchmarking Performance & Future …
The atrial fibrillation market is undergoing a period of rapid transformation as diagnostic technologies, catheter-based therapies, and antiarrhythmic solutions continue to advance. Atrial fibrillation (AFib) is one of the most prevalent cardiac arrhythmias globally, prompting significant demand for improved detection, early intervention, and minimally invasive treatment. The shift toward advanced ablation systems, AI-enabled diagnostics, wearable monitoring, and next-generation electro-mapping tools has strengthened competition across the market. Companies are expanding their
Conductive Textiles Market - Top Companies, SWOT Deep Dive & Capital Flow Trends
Conductive Textiles Market - Top Companies, SWOT Deep Dive & Capital Flow Trends
The conductive textiles market is undergoing a rapid transformation as wearable electronics, smart apparel, and advanced sensor-integrated fabrics move from niche applications to mainstream adoption. Conductive textiles-engineered using conductive polymers, metal-coated fibers, or intrinsically conductive yarns-have become integral to next-generation healthcare wearables, military gear, automotive interiors, and consumer smart devices. As industries push for lighter, flexible, and more energy-efficient electronic systems, conductive materials embedded within fabrics are emerging as a
Global Osteosynthesis Devices Market: Top Companies, Market Share Rankings & Investment Insights
Global Osteosynthesis Devices Market: Top Companies, Market Share Rankings & Inv …
The osteosynthesis devices market continues to evolve as orthopedic care moves toward minimally invasive procedures, biologically compatible materials, and technology-enabled implants. These devices-ranging from plates and screws to intramedullary nails and fixation systems-are essential for treating fractures, deformities, and complex bone injuries. Companies operating in this space are adopting strategies centered around product innovation, clinical efficacy, and expansion into fast-growing regions. As trauma care volumes rise in both developed and

All 5 Releases


More Releases for Prenatal

Non-Invasive Prenatal Testing (NIPT) Market Set to Transform Prenatal Care World …
Market Overview The global non-invasive prenatal testing NIPT market reached US$ 6.31 billion in 2023 and increased to US$ 7.35 billion in 2024. It is projected to reach US$ 22.41 billion by 2033, growing at a compound annual growth rate CAGR of 13.2% during the forecast period 2025-2033. The market is driven by the rising prevalence of chromosomal abnormalities, increasing maternal age, and growing demand for safe, non-invasive screening methods. NIPT
Unlocking the Future of Prenatal Care: Insights into the Australia Non-Invasive …
Australia's NIPT market is growing as more parents choose safe, early screening for chromosomal abnormalities. Driven by rising maternal age, advanced sequencing technology, and increasing awareness, NIPT offers high accuracy without invasive procedures. As labs expand test panels and policymakers consider broader reimbursement, NIPT is reshaping prenatal care, making comprehensive and reliable insights accessible to expecting families across Australia. The Australian non-invasive prenatal testing (NIPT) market is undergoing remarkable growth, transforming
Revolutionizing Prenatal Care: Insights into the Growing Non-Invasive Prenatal T …
Mordor Intelligence has published a new report on the Non-invasive Prenatal Testing Market, offering a comprehensive analysis of trends, growth drivers, and future projections. The global non-invasive prenatal testing (NIPT) market is projected to expand significantly, with expectations to grow from USD 3.90 billion in 2025 to USD 7.35 billion by 2030, reflecting a compound annual growth rate (CAGR) of 13.5%. This growth is primarily attributed to
Prenatal Diagnostics Market Companies Overview 2019 - 2027
Global Prenatal Diagnostics Market: Overview Prenatal diagnostics is a procedure for testing the fetus before birth to determine certain hereditary disorders such as Down's syndrome, genetic diseases, chromosome abnormalities, neural tube defects, and other conditions. In case of high risk related to the birth of a child, it can assist by conducting numerous procedures of genetic testing common testing, and screening. Report Overview @ https://www.transparencymarketresearch.com/prenatal-diagnostics-market.html The global prenatal diagnostics market is segmented on
Non-Invasive Prenatal Testing Market : Lucrative Opportunities
Non-Invasive Prenatal Testing Market: Introduction Transparency Market Research has published a new report titled 'Global Non-Invasive Prenatal Testing Market'. According to the report, the global non-invasive prenatal testing market was valued at approximately US$ 1.3 Bn in 2018. The global non-invasive prenatal testing market is expected to expand at a CAGR of 16.4% during the forecast period from 2019 to 2027. Overview Rise in prevalence of chronic conditions, such as cancer and diabetes,
Prenatal Vitamin Supplements Market: Rising Incidence of Prenatal Defects to Fue …
Global Prenatal Vitamin Supplements Market: Overview Prenatal vitamins are the mineral and vitamin supplements used by during their pregnancy for the healthy development of the fetus. Prenatal vitamins are also recommended by doctors before conception and post conception lactation period. These vitamins are like other common man multivitamins but with different concentration of vitamins and some special vitamins required during pregnancy. Most of these vitamins are prescribed as regulated by U.S.